Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities.
Saved in:
| Title: | Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. |
|---|---|
| Authors: | Estadt AT; College of Public Health, Division of Epidemiology, Ohio State University, 1841 Neil Avenue, Columbus, OH, 43210, USA. estadt.24@osu.edu., Kline D; Division of Public Health Sciences, Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Miller WC; Gillings School of Global Public Health, Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Feinberg J; Departments of Behavioral Medicine and Psychiatry & Medicine/Infectious Diseases, West Virginia University School of Medicine, Morgantown, WV, USA., Hurt CB; Institute for Global Health & Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mixson LS; Department of Medicine, University of Washington, Seattle, WA, USA., Friedmann PD; University of Massachusetts Medical School-Baystate and Baystate Health, Springfield, MA, USA., Lowe K; Department of Medicine, Division of Infectious Disease, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA., Tsui JI; Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA, USA., Young AM; Department of Epidemiology, Center on Drug and Alcohol Research, University of Kentucky, Lexington, KY, USA., Cooper H; Rollins School of Public Health, Emory University, Atlanta, GA, USA., Korthuis PT; Department of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, USA., Pho MT; Department of Medicine, University of Chicago, Chicago, IL, USA., Jenkins W; Department of Public Health Sciences, Clemson University, Clemson, SC, USA., Westergaard RP; Department of Medicine, Division of Infectious Disease, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA., Go VF; Gillings School of Global Public Health, Department of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Brook D; College of Medicine, Ohio State University, Columbus, OH, USA., Smith G; Department of Epidemiology and Biostatistics, West Virginia University School of Public Health, Morgantown, WV, USA., Rice DR; University of Massachusetts Chan School of Medicine, Worcester, MA, USA., Lancaster KE; Division of Public Health Sciences, Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA. |
| Source: | Harm reduction journal [Harm Reduct J] 2024 Nov 29; Vol. 21 (1), pp. 214. Date of Electronic Publication: 2024 Nov 29. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39614319 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Estadt+AT%22">Estadt AT</searchLink>; College of Public Health, Division of Epidemiology, Ohio State University, 1841 Neil Avenue, Columbus, OH, 43210, USA. estadt.24@osu.edu.<br /><searchLink fieldCode="AU" term="%22Kline+D%22">Kline D</searchLink>; Division of Public Health Sciences, Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Miller+WC%22">Miller WC</searchLink>; Gillings School of Global Public Health, Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Feinberg+J%22">Feinberg J</searchLink>; Departments of Behavioral Medicine and Psychiatry & Medicine/Infectious Diseases, West Virginia University School of Medicine, Morgantown, WV, USA.<br /><searchLink fieldCode="AU" term="%22Hurt+CB%22">Hurt CB</searchLink>; Institute for Global Health & Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Mixson+LS%22">Mixson LS</searchLink>; Department of Medicine, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Friedmann+PD%22">Friedmann PD</searchLink>; University of Massachusetts Medical School-Baystate and Baystate Health, Springfield, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lowe+K%22">Lowe K</searchLink>; Department of Medicine, Division of Infectious Disease, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Tsui+JI%22">Tsui JI</searchLink>; Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Young+AM%22">Young AM</searchLink>; Department of Epidemiology, Center on Drug and Alcohol Research, University of Kentucky, Lexington, KY, USA.<br /><searchLink fieldCode="AU" term="%22Cooper+H%22">Cooper H</searchLink>; Rollins School of Public Health, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Korthuis+PT%22">Korthuis PT</searchLink>; Department of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Pho+MT%22">Pho MT</searchLink>; Department of Medicine, University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Jenkins+W%22">Jenkins W</searchLink>; Department of Public Health Sciences, Clemson University, Clemson, SC, USA.<br /><searchLink fieldCode="AU" term="%22Westergaard+RP%22">Westergaard RP</searchLink>; Department of Medicine, Division of Infectious Disease, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Go+VF%22">Go VF</searchLink>; Gillings School of Global Public Health, Department of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Brook+D%22">Brook D</searchLink>; College of Medicine, Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Smith+G%22">Smith G</searchLink>; Department of Epidemiology and Biostatistics, West Virginia University School of Public Health, Morgantown, WV, USA.<br /><searchLink fieldCode="AU" term="%22Rice+DR%22">Rice DR</searchLink>; University of Massachusetts Chan School of Medicine, Worcester, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lancaster+KE%22">Lancaster KE</searchLink>; Division of Public Health Sciences, Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101153624%22">Harm reduction journal</searchLink> [Harm Reduct J] 2024 Nov 29; Vol. 21 (1), pp. 214. <i>Date of Electronic Publication: </i>2024 Nov 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101153624 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-7517 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214777517%22">14777517 </searchLink><i>NLM ISO Abbreviation: </i>Harm Reduct J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39614319 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12954-024-01131-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 214 Titles: – TitleFull: Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Estadt AT – PersonEntity: Name: NameFull: Kline D – PersonEntity: Name: NameFull: Miller WC – PersonEntity: Name: NameFull: Feinberg J – PersonEntity: Name: NameFull: Hurt CB – PersonEntity: Name: NameFull: Mixson LS – PersonEntity: Name: NameFull: Friedmann PD – PersonEntity: Name: NameFull: Lowe K – PersonEntity: Name: NameFull: Tsui JI – PersonEntity: Name: NameFull: Young AM – PersonEntity: Name: NameFull: Cooper H – PersonEntity: Name: NameFull: Korthuis PT – PersonEntity: Name: NameFull: Pho MT – PersonEntity: Name: NameFull: Jenkins W – PersonEntity: Name: NameFull: Westergaard RP – PersonEntity: Name: NameFull: Go VF – PersonEntity: Name: NameFull: Brook D – PersonEntity: Name: NameFull: Smith G – PersonEntity: Name: NameFull: Rice DR – PersonEntity: Name: NameFull: Lancaster KE IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 11 Text: 2024 Nov 29 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1477-7517 Numbering: – Type: volume Value: 21 – Type: issue Value: 1 Titles: – TitleFull: Harm reduction journal Type: main |
| ResultId | 1 |
